{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:54:15Z","timestamp":1782528855941,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1136\/ijgc-2023-004618","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T11:30:19Z","timestamp":1691148619000},"page":"1743-1749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathological findings and long-term prognosis in Korean BRCA1\/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4574-5124","authenticated-orcid":false,"given":"Ok-Ju","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Wha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2475-7123","authenticated-orcid":false,"given":"Jeong-Yeol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Shik","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hyeok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Tak","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004618_bb0010","first-page":"3776","article-title":"Ovarian cancer risk in ashkenazi jewish carriers of Brca1 and Brca2 mutations","volume":"8","author":"Satagopan","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2023-004618_bb0015","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ejhg.2017.126","article-title":"Third party interpretation of raw genetic data: an ethical exploration","volume":"25","author":"Badalato","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1136\/ijgc-2023-004618_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21037\/gs.2016.11.05","article-title":"Evaluating the performance of national comprehensive cancer network (NCCN) breast and ovarian genetic\/familial high risk assessment referral criteria for breast cancer women in an Asian surgical breast clinic","volume":"6","author":"Lim","year":"2017","journal-title":"Gland Surg"},{"key":"10.1136\/ijgc-2023-004618_bb0025","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of Brca1 or Brca2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-004618_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071050","article-title":"Differences in ovarian and other cancers risks by population and BRCA Mutation location","volume":"12","author":"Sekine","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1136\/ijgc-2023-004618_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a Brca1 or Brca2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-004618_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","article-title":"Brca1 and Brca2 mutations across race and ethnicity: distribution and clinical implications","volume":"22","author":"Kurian","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004618_bb0045","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal Carcinomatosis after risk-reducing Salpingo-Oophorectomy: A systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0050","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004618_bb0055","first-page":"5241","article-title":"Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: a single institution prospective series","volume":"37","author":"Ricciardi","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2023-004618_bb0060","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12094-018-1865-9","article-title":"Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study","volume":"20","author":"Minig","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13048-019-0525-1","article-title":"Development of peritoneal carcinoma in women diagnosed with serous Tubal intraepithelial carcinoma (STIC) following risk-reducing salpingo-oophorectomy (RRSO)","volume":"12","author":"Stanciu","year":"2019","journal-title":"J Ovarian Res"},{"key":"10.1136\/ijgc-2023-004618_bb0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2021.08.021","article-title":"Efficacy of risk-reducing salpingo-oophorectomy in Brca1-2 variants and clinical outcomes of follow-up in patients with isolated Serous Tubal intraepithelial carcinoma (STIC)","volume":"163","author":"Saccardi","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007","volume":"10","author":"Richards","year":"2008","journal-title":"Genet Med"},{"key":"10.1136\/ijgc-2023-004618_bb0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1136\/ijgc-2023-004618_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The Tubal Fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2023-004618_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004618_bb0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PGP.0b013e31824cbeb4","article-title":"Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Kuhn","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1136\/ijgc-2023-004618_bb0100","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of P53 can serve as a surrogate marker for Tp53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Yemelyanova","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2023-004618_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO Committee on gynecologic oncology. staging classification for cancer of the ovary, fallopian tube and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004618_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-010-0799-x","article-title":"Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of Brca1\/2 mutation carriers","volume":"124","author":"Domchek","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1136\/ijgc-2023-004618_bb0115","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1503523","article-title":"Risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-004618_bb0120","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e3","article-title":"Pathologic findings at risk-reducing Salpingo-Oophorectomy (RRSO) in Germline BRCA Mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in Germline BRCA Mutation carriers","volume":"28","author":"Lee","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","article-title":"Risk management options elected by women after testing positive for a BRCA Mutation","volume":"132","author":"Garcia","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/GME.0000000000001900","article-title":"Factors affecting surgical decision-making in carriers of Brca1\/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic","volume":"29","author":"Jacobson","year":"2021","journal-title":"Menopause"},{"key":"10.1136\/ijgc-2023-004618_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.critrevonc.2018.09.018","article-title":"Hormone replacement therapy after prophylactic risk-reducing Salpingo-Oophorectomy and breast cancer risk in Brca1 and Brca2 Mutation carriers: a meta-analysis","volume":"132","author":"Marchetti","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/ijgc-2023-004618_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinomas: a unifying hypothesis","volume":"30","author":"Auersperg","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1136\/ijgc-2023-004618_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041141","article-title":"Prophylactic radical Fimbriectomy with delayed oophorectomy in women with a high risk of developing an ovarian carcinoma: results of a prospective national pilot study","volume":"15","author":"Leblanc","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1136\/ijgc-2023-004618_bb0150","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ijgc-2023-004377","article-title":"Tubectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol","volume":"33","author":"Steenbeek","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004618_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2018.05.011","article-title":"Age-specific ovarian cancer risks among women with a Brca1 or Brca2 Mutation","volume":"150","author":"Kotsopoulos","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1136\/ijgc-2023-004618_bb0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2015.09.018","article-title":"Clinical outcomes in patients with isolated Serous Tubal intraepithelial carcinoma (STIC): a comprehensive review","volume":"139","author":"Patrono","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA Mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/cco-20-34","article-title":"Epidemiology of ovarian cancer","volume":"9","author":"Gaona-Luviano","year":"2020","journal-title":"Chin Clin Oncol"},{"key":"10.1136\/ijgc-2023-004618_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24017791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24017791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:18:30Z","timestamp":1753229910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24017791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1048891X24017791"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004618","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological findings and long-term prognosis in Korean BRCA1\/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}